208
78. Nicholson WL, Munakata N, Horneck G, Melosh HJ, Setlow P (2000) Resistance of Bacillus
endospores to extreme terrestrial and extraterrestrial environments. Microbiol Mol Biol Rev
64:548–572
79. Boutiba-Ben Boubaker I, Ben Redjeb S (2001) Bacillus anthracis : causative agent of anthrax.
Tunis Med 79:642–646
80. Read TD, Salzberg SL, Pop M, Shumway M, Umayam L, Jiang L, Holtzapple E, Busch JD,
Smith KL, Schupp JM, Solomon D, Keim P, Fraser CM (2002) Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis. Science 296:2028–2033
81. Turnbull PCB (1999) Defi nitive identifi cation of Bacillus anthracis -a review. J Appl
Microbiol 87:237–240
82. Reed LJ, Muench H (1938) A simple method for estimating fifty percent endpoints. Am J Hyg
27:493–497
83. Hoffmaster AR, Fitzgerald CC, Ribot E, Mayer LW, Popovic T (2002) Molecular subtyping
of Bacillus anthracis and the 2001 bioterrorism-associated anthrax outbreak, United States.
Emerg Infect Dis 8:1111–1116
84. Chun J-H, Hong K-J, Cha SH, Cho M-H, Lee KJ, Jeong DH, Yoo C-K, Rhie G-e (2012)
Complete genome sequence of Bacillus anthracis H9401, an isolate from a Korean patient
with anthrax. J Bacteriol 194:4116–4117
85. Williams DD, Benedek O, Turnbough CL Jr (2003) Species-specifi c peptide ligands for the
detection of Bacillus anthracis spores. Appl Environ Microbiol 69:6288–6293
86. Chabot DJ, Scorpio A, Tobery SA, Little SF, Norris SL, Friedlander AM (2004) Anthrax capsule vaccine protects against experimental infection. Vaccine 23:43–47
87. Daubenspeck JM, Zeng H, Chen P, Dong S, Steichen CT, Krishna NR, Pritchard DG Jr,
Turnbough CL (2004) Novel oligosaccharide side chains of the collagen-like region of BclA,
the major glycoprotein of the Bacillus anthracis exosporium. J Biol Chem 279:30945–30953
88. Burkitt WI, Giannakopulos AE, Sideridou F, Bashir S, Derrick PJ (2003) Discrimination effects
in MALDI-MS of mixtures of peptides-analysis of the proteome. Aust J Chem 56:369–377
89. Kratzer R, Eckerskorn C, Karas M, Lottspeich F (1998) Suppression effects in enzymatic peptide ladder sequencing using ultraviolet – matrix assisted laser desorption/ionization – mass
spectrometry. Electrophoresis 19:1910–1919
M. Bologna et al.
78. Nicholson WL, Munakata N, Horneck G, Melosh HJ, Setlow P (2000) Resistance of Bacillus
endospores to extreme terrestrial and extraterrestrial environments. Microbiol Mol Biol Rev
64:548–572
79. Boutiba-Ben Boubaker I, Ben Redjeb S (2001) Bacillus anthracis : causative agent of anthrax.
Tunis Med 79:642–646
80. Read TD, Salzberg SL, Pop M, Shumway M, Umayam L, Jiang L, Holtzapple E, Busch JD,
Smith KL, Schupp JM, Solomon D, Keim P, Fraser CM (2002) Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis. Science 296:2028–2033
81. Turnbull PCB (1999) Defi nitive identifi cation of Bacillus anthracis -a review. J Appl
Microbiol 87:237–240
82. Reed LJ, Muench H (1938) A simple method for estimating fifty percent endpoints. Am J Hyg
27:493–497
83. Hoffmaster AR, Fitzgerald CC, Ribot E, Mayer LW, Popovic T (2002) Molecular subtyping
of Bacillus anthracis and the 2001 bioterrorism-associated anthrax outbreak, United States.
Emerg Infect Dis 8:1111–1116
84. Chun J-H, Hong K-J, Cha SH, Cho M-H, Lee KJ, Jeong DH, Yoo C-K, Rhie G-e (2012)
Complete genome sequence of Bacillus anthracis H9401, an isolate from a Korean patient
with anthrax. J Bacteriol 194:4116–4117
85. Williams DD, Benedek O, Turnbough CL Jr (2003) Species-specifi c peptide ligands for the
detection of Bacillus anthracis spores. Appl Environ Microbiol 69:6288–6293
86. Chabot DJ, Scorpio A, Tobery SA, Little SF, Norris SL, Friedlander AM (2004) Anthrax capsule vaccine protects against experimental infection. Vaccine 23:43–47
87. Daubenspeck JM, Zeng H, Chen P, Dong S, Steichen CT, Krishna NR, Pritchard DG Jr,
Turnbough CL (2004) Novel oligosaccharide side chains of the collagen-like region of BclA,
the major glycoprotein of the Bacillus anthracis exosporium. J Biol Chem 279:30945–30953
88. Burkitt WI, Giannakopulos AE, Sideridou F, Bashir S, Derrick PJ (2003) Discrimination effects
in MALDI-MS of mixtures of peptides-analysis of the proteome. Aust J Chem 56:369–377
89. Kratzer R, Eckerskorn C, Karas M, Lottspeich F (1998) Suppression effects in enzymatic peptide ladder sequencing using ultraviolet – matrix assisted laser desorption/ionization – mass
spectrometry. Electrophoresis 19:1910–1919
M. Bologna et al.